Article, 2024

Patient-reported outcomes after personalised dose-escalation for stage II-III non-small-cell lung cancer patients: Results from the randomised ARTFORCE PET-Boost trial

RADIOTHERAPY AND ONCOLOGY, ISSN 0167-8140, Volume 196, 10.1016/j.radonc.2024.110312

Contributors

Cooke, Saskia A. (Corresponding author) [1] Belderbos, Jose S. A. (Corresponding author) [1] Reymen, B. [2] [3] Lambrecht, Maarten [4] [5] Persson, Gitte Fredberg [6] [7] Faivre-Finn, C. [8] [9] Dieleman, Edith M. T. [10] van Diessen, Judi N. A. [1] Sonke, Jan-Jakob [1] De Ruysscher, D. [2] [3]

Affiliations

  1. [1] Netherlands Canc Inst NKI AVL, Dept Radiat Oncol, Amsterdam, Netherlands
    2. [NORA names: Netherlands; Europe, EU; OECD];
  2. [2] Maastricht Univ, GROW Sch Oncol & Dev Biol, Dept Radiat Oncol, MAASTRO Clin,Med Ctr, Maastricht, Netherlands
    3. [NORA names: Netherlands; Europe, EU; OECD];
  3. [3] Maastricht Univ, GROW Sch Oncol & Dev Biol, Dept Radiat Oncol, MAASTRO Clin,Med Ctr, Maastricht, Netherlands
    4. [NORA names: Netherlands; Europe, EU; OECD];
  4. [4] Univ Hosp Leuven, Dept Radiotherapy Oncol, Gasthuisberg, Belgium
    5. [NORA names: Belgium; Europe, EU; OECD];
  5. [5] Univ Hosp Leuven, Dept Radiotherapy Oncol, Gasthuisberg, Belgium
    6. [NORA names: Belgium; Europe, EU; OECD];

Abstract

Abstract not displayed. As this article is not marked as Open Access, it is unclear if we are allowed to show the abstract. Please use the link in the sidebar to view the data provider version of the article including abstract.

Keywords

Carcinoma non-small-cell-lung, Carcinoma non-small-cell-lung / Radiotherapy, Clinical trials, Patient reported outcome measures*, Quality of life*, Radiotherapy dosage

Data Provider: Clarivate

LINKS
-

Matching Records in NORA

SUBJECTS
+

METRICS
+